HK1021732A1 - Arylalkanoyl pyridazine derivatives and preparing thereof, pharmaceutical containing the same and their use - Google Patents

Arylalkanoyl pyridazine derivatives and preparing thereof, pharmaceutical containing the same and their use

Info

Publication number
HK1021732A1
HK1021732A1 HK00100584A HK00100584A HK1021732A1 HK 1021732 A1 HK1021732 A1 HK 1021732A1 HK 00100584 A HK00100584 A HK 00100584A HK 00100584 A HK00100584 A HK 00100584A HK 1021732 A1 HK1021732 A1 HK 1021732A1
Authority
HK
Hong Kong
Prior art keywords
arylalkanoyl
preparing
same
pyridazine derivatives
pharmaceutical containing
Prior art date
Application number
HK00100584A
Other languages
English (en)
Inventor
Jonas Rochus
Norbert Beier
Franz-Werner Kluxen
Michael Wolf
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of HK1021732A1 publication Critical patent/HK1021732A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
HK00100584A 1996-08-13 2000-01-31 Arylalkanoyl pyridazine derivatives and preparing thereof, pharmaceutical containing the same and their use HK1021732A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19632549A DE19632549A1 (de) 1996-08-13 1996-08-13 Arylalkanoylpyridazine
PCT/EP1997/004191 WO1998006704A1 (fr) 1996-08-13 1997-08-01 Arylalcanoylpyridazines

Publications (1)

Publication Number Publication Date
HK1021732A1 true HK1021732A1 (en) 2000-06-30

Family

ID=7802479

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00100584A HK1021732A1 (en) 1996-08-13 2000-01-31 Arylalkanoyl pyridazine derivatives and preparing thereof, pharmaceutical containing the same and their use

Country Status (24)

Country Link
US (1) US6479494B1 (fr)
EP (1) EP0922036B1 (fr)
KR (1) KR100554876B1 (fr)
CN (1) CN1109022C (fr)
AR (1) AR009069A1 (fr)
AT (1) ATE262512T1 (fr)
AU (1) AU725652B2 (fr)
BR (1) BR9711066A (fr)
CA (1) CA2263417C (fr)
CZ (1) CZ291851B6 (fr)
DE (2) DE19632549A1 (fr)
DK (1) DK0922036T3 (fr)
ES (1) ES2214633T3 (fr)
HK (1) HK1021732A1 (fr)
HU (1) HUP0001760A3 (fr)
NO (1) NO312295B1 (fr)
PL (1) PL331557A1 (fr)
PT (1) PT922036E (fr)
RU (1) RU2201923C2 (fr)
SI (1) SI0922036T1 (fr)
SK (1) SK282480B6 (fr)
TW (1) TW427980B (fr)
WO (1) WO1998006704A1 (fr)
ZA (1) ZA977206B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19826841A1 (de) * 1998-06-16 1999-12-23 Merck Patent Gmbh Arylalkanoylpyridazine
DE19850701A1 (de) * 1998-11-04 2000-05-11 Merck Patent Gmbh Benzoylpyridazine
DE19915365A1 (de) * 1999-04-06 2000-10-12 Merck Patent Gmbh Tetrahydropyridazin-Derivate
DE19915364A1 (de) * 1999-04-06 2000-10-12 Merck Patent Gmbh Verwendung von Arylalkanoylpyridazinen
DE19932315A1 (de) 1999-07-10 2001-01-11 Merck Patent Gmbh Benzoylpyridazine
SI1212089T1 (sl) 1999-08-21 2006-08-31 Altana Pharma Ag Sinergisticna kombinacija roflumilasta in salmeterola
US6794132B2 (en) 1999-10-02 2004-09-21 Biosite, Inc. Human antibodies
US7135287B1 (en) 1999-10-02 2006-11-14 Biosite, Inc. Human antibodies
US6680209B1 (en) 1999-12-06 2004-01-20 Biosite, Incorporated Human antibodies as diagnostic reagents
DE10064997A1 (de) 2000-12-23 2002-06-27 Merck Patent Gmbh Benzoylpyridazine
CN1235589C (zh) * 2001-02-12 2006-01-11 默克专利股份公司 4型磷酸二酯酶抑制剂在制备治疗心肌疾病药物中的应用
CA2462525A1 (fr) * 2001-10-31 2003-05-08 Merck Patent Gesellschaft Mit Beschraenkter Haftung Inhibiteurs de la phosphodiesterase de type 4 et leurs utilisations
US7141572B2 (en) 2001-11-05 2006-11-28 Merck Patent Gesellschaft Hydrazono-malonitriles
DE10224888A1 (de) * 2002-06-05 2003-12-24 Merck Patent Gmbh Pyridazinderivate
DE10225574A1 (de) 2002-06-10 2003-12-18 Merck Patent Gmbh Aryloxime
DE10227269A1 (de) * 2002-06-19 2004-01-08 Merck Patent Gmbh Thiazolderivate
EP2258359A3 (fr) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenèse par modulation des récepteurs muscariniques avec sabcomeline
EP2275095A3 (fr) 2005-08-26 2011-08-17 Braincells, Inc. Neurogenese par modulation des recepteurs muscariniques
EP2377530A3 (fr) 2005-10-21 2012-06-20 Braincells, Inc. Modulation de neurogénèse par inhibition PDE
EP2314289A1 (fr) 2005-10-31 2011-04-27 Braincells, Inc. Modulation de la neurogenese dont la médiation est assurée par récepteur gaba
MY153720A (en) 2005-11-15 2015-03-13 Otsuka Pharma Co Ltd Oxazole compound and pharmaceutical composition
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
WO2007134077A2 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenèse induite par le récepteur 5ht
CA2651813A1 (fr) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenese par modulation de l'angiotensine
AU2007292848A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
EP2804603A1 (fr) 2012-01-10 2014-11-26 President and Fellows of Harvard College Composés promoteurs de réplication des cellules bêta et leurs procédés d'utilisation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2139307A1 (fr) 1992-07-01 1994-01-20 Donald W. Combs 1-arylsulfonyl, arylcarbonyl et 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines

Also Published As

Publication number Publication date
AR009069A1 (es) 2000-03-08
HUP0001760A3 (en) 2001-07-30
NO990676D0 (no) 1999-02-12
ATE262512T1 (de) 2004-04-15
EP0922036B1 (fr) 2004-03-24
NO990676L (no) 1999-02-12
DE59711450D1 (en) 2004-04-29
AU4013397A (en) 1998-03-06
KR20000029921A (ko) 2000-05-25
ES2214633T3 (es) 2004-09-16
SK16899A3 (en) 1999-12-10
DE19632549A1 (de) 1998-02-19
SI0922036T1 (en) 2004-06-30
ZA977206B (en) 1999-11-12
PT922036E (pt) 2004-06-30
BR9711066A (pt) 1999-08-17
CA2263417A1 (fr) 1998-02-19
CN1227547A (zh) 1999-09-01
SK282480B6 (sk) 2002-02-05
TW427980B (en) 2001-04-01
CZ49399A3 (cs) 1999-05-12
DK0922036T3 (da) 2004-07-26
WO1998006704A1 (fr) 1998-02-19
HUP0001760A2 (hu) 2001-05-28
RU2201923C2 (ru) 2003-04-10
NO312295B1 (no) 2002-04-22
US6479494B1 (en) 2002-11-12
JP2001503022A (ja) 2001-03-06
KR100554876B1 (ko) 2006-02-24
EP0922036A1 (fr) 1999-06-16
JP4198755B2 (ja) 2008-12-17
AU725652B2 (en) 2000-10-19
CA2263417C (fr) 2006-03-28
PL331557A1 (en) 1999-07-19
CZ291851B6 (cs) 2003-06-18
CN1109022C (zh) 2003-05-21

Similar Documents

Publication Publication Date Title
HK1021732A1 (en) Arylalkanoyl pyridazine derivatives and preparing thereof, pharmaceutical containing the same and their use
HUP9903691A3 (en) Pesticidal karbanilide derivatives, preparation and use thereof
HUP9904051A3 (en) 4-hetaroylpyrazol derivatives, preparation and use thereof as herbicides
HUP0101099A3 (en) Substituted pyridine and pyridazine compounds and their pharmaceutical use
HU0500549D0 (en) Azolo-pyridimidines, pharmaceutical compositions containing the same and use thereof
HUP0100059A3 (en) Novel pyridazine derivatives and drugs containing the same as the active ingredient
GR970300037T1 (en) Phenol-derivatives having pharmaceutical activity and process for preparing the same
SG87776A1 (en) Substituted isoquinoline-3-carboxamides, their preparation and their use as pharmaceuticals
SI1019358T1 (en) 3,3-diarylpropylamines , their use and preparation
AU4679297A (en) 3-hydroxypyridine-2-carboxamidoesters, their preparation and their use as pharmaceuticals
HUP9902449A3 (en) Androstene derivatives, medicaments containing the same and their use
HU9501086D0 (en) Organoaluminoxy product, preparation and use
IL116525A0 (en) Piperazinedione derivatives their preparation and use
HUP9901685A3 (en) Colchicine derivatives, the use thereof and formulations containing them
IL129927A0 (en) 1,4-Diazabicyclo (2.2.2) oct-2-ylmethyl derivatives their preparation and therapeutic application
IL109437A0 (en) 2-Amino-4-quinolyldihydropyridines, processes for their preparation and their use
ZA976479B (en) Alfa-amino acids amides, preparation thereof and the therapeutical use thereof.
AU2030197A (en) 2-aminoethyl-benzofuran derivatives, preparation thereof and therapeutical use thereof
HUP9903649A3 (en) Taxane derivatives, the preparation thereof and medical formulations containing them
IL135520A0 (en) 8-azabicyclo [3.2.1.] octane-3-methanamine derivatives, their preparation and their therapeutic application
ZA926132B (en) New pyrazine derivatives,the preparation and use thereof
AU3650695A (en) New heterocyclic substituted imidazoloquinoxalinones, their preparation and their use
EP0442086A3 (en) Graftcopolymers, their preparation and their use
AU3023497A (en) Phthalazine derivatives, their preparation and their use as drugs
GB2324090B (en) 5,6-O-alkylidene glucono-1(4)-lactones and derivatives thereof,their preparation and use

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20070801